Florina R.
- Country
- Romania
- Department
- Pediatric Psychiatry
Research Overview
- A study to evaluate the effectiveness and safety of trospium chloride and xanomeline tartrate for treating schizophrenia in adolescents aged 13 to 17 years.
- Safety and Tolerability of KarXT in Adolescents with Schizophrenia and KarXT+KarX-EC in Children/Adolescents with Autism‑Related Irritability
- Evaluation of Intranasal Esketamine and Oral Midazolam for Rapid Symptom Reduction in Adolescent Major Depressive Disorder with Acute Suicidal Ideation
Data & Insights
Has run more than one trial at 11 of 58 partner sites.
Specializations
Schizophrenia and related psychotic disorders
Florina Rad is involved in clinical research on schizophrenia, including acute psychotic presentations, persistent symptoms, and treatment-resistant disease. Her work also extends to adolescent schizophrenia and psychosis with cognitive and behavioral impairment.
- Acute schizophrenia
- Negative and residual symptoms
- Adolescent psychosis
- Cognitive impairment in schizophrenia
Her psychiatric research also includes adjunctive and novel therapeutic strategies aimed at symptom control and functional improvement in psychotic illness.
Bipolar disorder and manic syndromes
Her clinical trial activity includes bipolar I disorder, with emphasis on acute mania and mania with mixed features. The research landscape reflects interest in both standalone and adjunctive approaches for mood stabilization.
- Bipolar I disorder
- Acute mania
- Mania with mixed features
- Relapse prevention in mood disorder
This area highlights a therapeutic focus on controlling severe mood elevation and maintaining longer-term symptom stability.
Alzheimer’s disease and neuropsychiatric symptoms
Florina Rad is active in studies addressing the psychiatric and behavioral complications of Alzheimer’s disease, particularly psychosis and agitation. Her research also covers cognitive and global functioning in mild to moderate disease.
- Psychosis associated with Alzheimer’s disease
- Agitation associated with Alzheimer’s dementia
- Hallucinations and delusions
- Cognitive and global functioning impairment
Her involvement spans therapeutic targets for neuropsychiatric symptoms that complicate dementia care.
Depressive disorders and suicidal risk
Her research portfolio includes major depressive disorder, especially depressive states with anhedonia and insomnia symptoms, as well as relapse prevention in depression. She is also involved in work on adolescent depression with acute suicidal ideation or behavior.
- Major depressive disorder
- Anhedonic depression
- Depression with insomnia symptoms
- Adolescent suicidal ideation
This area reflects a therapeutic interest in both symptom reduction and prevention of depressive recurrence.
Neurology and pediatric neurodevelopmental disorders
Her clinical trial involvement also includes neurological conditions such as multiple sclerosis, migraine, epilepsy, and Tourette’s disorder, with a notable pediatric focus in several of these areas.
- Relapsing-remitting multiple sclerosis
- Pediatric migraine
- Childhood absence epilepsy and juvenile absence epilepsy
- Tourette’s disorder
Her research interests cover neurologic symptom control and long-term management in children, adolescents, and young adults.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.